NCT01863030已完成不适用
A Prospective, Observational Study Utilizing Phasix™ Mesh During Ventral and Incisional Hernia Repair Surgery
John Roth1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2013年5月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 31
- 试验地点
- 1
- 主要终点
- Number of Participants With Recurrent Ventral and Incision Hernias Post Repair With Phasix™ Mesh
研究概览
简要总结
The objective of this study is to collect efficacy, safety and utility data with Phasix™ Mesh in ventral and incisional repair procedures by evaluating the following:
- Hernia recurrence rate of ventral and incisional hernias post repair with Phasix™ Mesh for up to 12 months post surgery.
- Perioperative, short-term and long-term procedural and/or device related complications.
- Abdominal Wall Function and mobility.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The subject must meet all of the relevant criteria listed below to be enrolled in the study:
- •Subject must be ≥18 years of age.
- •Subject or subject's legally authorized representative must be willing give written informed consent.
- •Subject must be diagnosed with a ventral, incisional or first-recurrent incisional hernia.
- •Hernia size greater than 10cm2 and less than 250cm2
- •Subject must be willing to undergo ventral hernia repair and be able to undergo all other study procedures as outlined in this protocol.
排除标准
- •The subject must be excluded from study enrollment if any of the following criteria are met:
- •Subject's hernia is multiply recurrent.
- •CDC wound classification other than clean or clean-contaminated
- •The use of surgical repair as a bridge.
- •Patient has a contraindication to placement of mesh.
- •Concomitant procedures with wound classification other than clean
- •Subject has peritonitis.
- •Subject is on or suspected to be placed on chemotherapy medications during any part of the study.
- •Subject's body mass index (BMI) >55 kg/m
- •Subject has cirrhosis, and/or ascites.
- •Subject is American Society of Anesthesiology Class 4 or
- •Subject is known to be infected with human immunodeficiency virus (HIV).
- •Subject has known allergies to tetracycline or kanamycin.
- •Subject has a life expectancy of less than 2 years at the time of enrollment.
- •Subject has any condition in the opinion of the Investigator that would preclude the use of the study device, or preclude the subject from completing the follow-up requirements.
结局指标
主要结局
Number of Participants With Recurrent Ventral and Incision Hernias Post Repair With Phasix™ Mesh
时间窗: up to 24 months post surgery
Number of participants with recurrent ventral and incision hernias post repair with Phasix™ Mesh. Hernia recurrence is measured by physical exam.
次要结局
未报告次要终点
研究者
John Roth
PI
University of Kentucky
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Study of Phasix™ Mesh for VHWG Grade 3 Midline Hernia RepairHernia, AbdominalHerniaHernia, IncisionalNCT02720042C. R. Bard84
已完成
不适用
A Prospective, Multicenter All Comers Study of Phasix Mesh for Ventral or Incisional Hernia RepairVentral HerniaIncisional HerniaNCT02053168C. R. Bard33
进行中（未招募）
不适用
Prophylactic Reinforcement of Ventral Abdominal Incisions TrialOpen Midline LaparotomyNCT03911700C. R. Bard477
已完成
不适用
Biological Mesh Versus Synthetic Mesh in Interdisciplinary RRP With SCPPelvic Organ ProlapseRectal ProlapseIntestinal ObstructionNCT06245577Evangelisches Klinikum Köln Weyertal gGmbH30
招募中
不适用
Mesh Vs Pledgets for Repair of Paraesophageal HerniaParaesophageal HerniaGERDNCT05974722David Krpata164